Log In
Print
BCIQ
Print
Print this Print this
 

Zmapp

  Manage Alerts
Collapse Summary General Information
Company Mapp Biopharmaceutical Inc.
DescriptionCombination of 3 mAbs targeting Ebola glycoproteins GP1 and GP2
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationEbola
Indication DetailsTreat Ebola infection
Regulatory Designation

Partner

Defyrus Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today